PanGen Biotech Inc. (KOSDAQ: 222110)

PanGen Biotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,135	45.4	838.28	8,901	8,139	4,363
Short-Term Investments	3,852	149.24	2	15,199	10,550	20,000
Cash & Short-Term Investments	5,987	194.65	840.28	24,100	18,689	24,363
Cash Growth	1307.14%	-76.84%	-96.51%	28.95%	-23.29%	-15.78%
Accounts Receivable	1,515	2,208	689.81	1,089	535.34	55.88
Other Receivables	15.98	8.54	221.29	241.03	176.87	143.3
Receivables	1,781	2,330	974.1	1,393	775.21	262.18
Inventory	7,083	6,925	6,630	4,373	3,764	799.78
Prepaid Expenses	79.35	58.91	71.41	21.39	15.49	8.16
Other Current Assets	314.64	333.62	60.91	1,267	847.87	173.93
Total Current Assets	15,245	9,843	8,576	31,154	24,092	25,607
Property, Plant & Equipment	5,972	6,240	6,608	6,748	6,029	7,011
Long-Term Investments	0	0	0	-0	0	-
Other Intangible Assets	797.39	879.93	269.63	313.41	271.58	269.71
Long-Term Deferred Charges	2,786	3,278	3,933	4,589	5,244	5,900
Other Long-Term Assets	574.07	501.5	1,287	473.47	673.02	295.16
Total Assets	25,374	20,741	20,674	43,277	36,309	39,083
Accounts Payable	243.88	298.82	255.48	381.91	296.57	601.76
Short-Term Debt	2,278	2,014	-	18,692	18,399	17,386
Current Portion of Leases	1.34	1.69	1.56	1.43	-	-
Other Current Liabilities	2,096	3,396	872.49	811.14	1,395	919.8
Total Current Liabilities	4,620	5,711	1,130	19,886	20,091	18,907
Long-Term Leases	1.33	2.24	3.93	5.49	-	-
Other Long-Term Liabilities	30	30	206.41	116.22	77.31	-
Total Liabilities	7,355	8,175	3,454	22,179	22,098	20,657
Common Stock	5,707	5,339	5,339	5,336	4,821	4,821
Additional Paid-In Capital	61,031	57,402	57,402	57,371	47,840	47,840
Retained Earnings	-49,420	-50,876	-46,210	-42,062	-38,680	-34,436
Comprehensive Income & Other	700.82	700.82	688.64	452.86	229.89	201.9
Total Common Equity	18,019	12,566	17,219	21,098	14,211	18,426
Shareholders' Equity	18,019	12,566	17,219	21,098	14,211	18,426
Total Liabilities & Equity	25,374	20,741	20,674	43,277	36,309	39,083
Total Debt	2,281	2,018	5.49	18,699	18,399	17,386
Net Cash (Debt)	3,706	-1,823	834.79	5,402	290.4	6,977
Net Cash Growth	-	-	-84.55%	1760.05%	-95.84%	-45.30%
Net Cash Per Share	335.19	-170.76	78.21	528.69	30.13	723.69
Filing Date Shares Outstanding	11.41	10.68	10.68	10.67	9.64	9.64
Total Common Shares Outstanding	11.41	10.68	10.68	10.67	9.64	9.64
Working Capital	10,625	4,132	7,447	11,267	4,001	6,700
Book Value Per Share	1578.58	1176.85	1612.67	1976.95	1473.91	1911.10
Tangible Book Value	17,222	11,686	16,950	20,784	13,940	18,157
Tangible Book Value Per Share	1508.73	1094.44	1587.42	1947.58	1445.75	1883.13
Land	1,174	1,174	1,174	1,174	1,004	1,132
Buildings	3,909	3,909	3,909	3,909	3,456	3,857
Machinery	11,767	11,545	11,434	10,381	9,811	9,368
Construction In Progress	-	125.36	-	332.66	1.11	98.09

Source: S&P Capital IQ. Standard template. Financial Sources.